The partnership follows Bio-Pharmaceutical Plus’ recent launch into the Australian pharmaceuticals, cosmetics, and health foods market.Brisbane, Australia – Bio-Pharmaceutical Plus has announced its partnership with Wonderful Capital Biotechnology Group (WCBG), an industry partner of the Australia Research Council (ARC), to manufacture pharmaceuticals, cosmetics and functional health foods and offer its products globally.
Since its founding in 2018 as a joint lab company with several Australian universities, WCBG has grown to be the top pharmaceutical contract manufacturer in the country. The company is also an industry partner of the ARC Centre for Green Chemistry in Manufacturing.
WCBG provides customized contract manufacturing services for customers who want to outsource their pharmaceutical products, cosmetics and healthcare foods to be more competitive and develop new formulations feasible in the market. The company features a unique, specialized production system with total outsourcing services on development and production of pharmaceuticals and quasi-drugs.
“We are pleased to announce our valuable partnership with the renowned WCBG,” said Rory Sinclair, CEO of Bio-Pharmaceutical Plus. “WCBG’s extensive research, expertise and technology from leading Australian laboratories will allow us to provide consumers with high quality pharmaceuticals, cosmetics and functional health foods that rival others on the market.”
WCBG conducts highly innovative biotechnology research specializing in marine biotechnology and biocatalysts technology. The company and its partners have conducted technical research for the purposes of R&D, extraction, production, filling, packaging and marketing in Australia and New Zealand. This high-quality research involves health service solutions, testing and evaluation products, and the establishment of enterprise-scientific research expert workstations.
Learn more about Bio-Pharmaceutical Plus and WCBG at bio-pharmaceuticalplus.com.
About Bio-Pharmaceutical Plus
Bio-Pharmaceutical Plus, a distributor of high quality pharmaceutical products, was founded in March 2022 in Australia. Bio-pharmaceutical Plus works hand-in-hand with Wonderful Capital Biotechnology Group (WCBG), an Australian company that conducts highly innovative biotechnology research specializing in marine biotechnology and biocatalysts technology.
For more information, visit www.bio-pharmaceuticalplus.com.
Media Contact
Company Name: Bio-Pharmaceutical Plus
Contact Person: Rory Sinclair
Email: Send Email
Country: Australia
Website: https://www.bio-pharmaceuticalplus.com/
